Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras
about
Biomarkers in vasculitisEndothelial Response to Glucocorticoids in Inflammatory DiseasesTherapeutic effects of acetylsalicylic acid in giant cell arteritisTransient opening of the perineurial barrier for analgesic drug deliveryDisease pattern in cranial and large-vessel giant cell arteritis.Th17 and Th1 T-cell responses in giant cell arteritis.Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids.Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects.Vascular damage in giant cell arteritis.Immune mechanisms in medium and large-vessel vasculitis.IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritisSerpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritisReactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillariesTrapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis.Tissue cytokine patterns distinguish variants of rheumatoid synovitis.Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cellsCD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis.Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritisPredictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases.Giant Cell Arteritis: Beyond Corticosteroids.Effects of prednisolone treatment on cytokine expression in patients with leprosy type 1 reactions.Design of the tocilizumab in giant cell arteritis trial.Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis.Stress sensors of skeletal muscle: heat shock-induced cytokine expression. Focus on "skeletal muscle interleukin-6 regulation in hyperthermia".Induction of pituitary cytokine transcripts by peripheral lipopolysaccharide.Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis.Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review
P2860
Q26825345-8526F635-E65A-454A-B0C3-64E2AB7E6685Q28073947-A9753C51-EF0B-432C-8AC9-10B203824DB6Q28192358-856F26A6-FEF1-46D0-A05B-7CF1D33B0A7EQ28568470-DD761529-33EE-4A37-BE95-E5D63DE54777Q33534693-080ADDDE-1142-4B3F-8866-E71C294A70F0Q33723160-28048A34-AA9A-4D1C-8949-3107A3A47AECQ33848421-72F5A924-7246-4632-97CD-89146AAE6F9DQ34328150-CDD2CCD8-13C4-49FE-B194-485164517012Q34580606-AFA2611D-4C39-4A44-8F10-77BA53AF9B71Q34743236-7C547B63-2A66-4244-8418-66E0D8B86218Q34777943-34BFBC05-3FFE-41E7-BC88-C1C7B9F56C2FQ34847819-6563ADC9-7645-4616-943D-3829EBD0F977Q35058267-8D7F0A9F-6ED8-4098-A85B-6B61FEF49F51Q35747507-DF2D6C5A-8E70-484E-844C-0DBB8CE07BF7Q35747868-D1FE7B2E-5FB5-40B5-A362-5190440B3F2FQ35764078-D85D5C26-96B8-4F4E-BE49-7DDF373FD29AQ35787897-F191F4D8-A2AB-45D2-8EAC-F6349844543DQ36370272-14A20C68-4B6E-4F21-A580-52A2D8414CC7Q36399030-5A99A678-9EEC-488E-AE3D-E80A45C5B13DQ37082033-4AEF12D0-CA21-420D-91AD-D858A6ADA45DQ37289670-0180A59B-4078-43FC-BCA4-B509558194CCQ38560322-B60F54A2-8756-49FB-8713-50A82A1D9A0DQ38874908-6FF2BCE6-27DB-4C91-8225-99A8A23F6329Q40195385-1E529A16-C704-4B7E-ABF3-564FBECFBCFDQ45034871-4F583CB7-706D-437E-8CB8-51EFF2F981E7Q45823861-1EFED4D2-63C3-44E8-8C26-B5714E5036BEQ48275178-8B8990DD-B388-41E5-9B05-05404530046FQ51033475-F7289587-D510-4E05-BA75-93AEAE87C9CBQ52893205-BAA35278-E842-4B4E-A6C9-51F19B32C224Q54238129-0576C8CD-DF00-4B68-852B-23CB4659323DQ56889607-D1A067C1-89C1-4FD5-AF1C-6484431A0F69
P2860
Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Glucocorticoid-mediated repres ...... human arteritis-SCID chimeras
@en
Glucocorticoid-mediated repres ...... human arteritis-SCID chimeras.
@nl
type
label
Glucocorticoid-mediated repres ...... human arteritis-SCID chimeras
@en
Glucocorticoid-mediated repres ...... human arteritis-SCID chimeras.
@nl
prefLabel
Glucocorticoid-mediated repres ...... human arteritis-SCID chimeras
@en
Glucocorticoid-mediated repres ...... human arteritis-SCID chimeras.
@nl
P2093
P2860
P356
P1476
Glucocorticoid-mediated repres ...... human arteritis-SCID chimeras
@en
P2093
B R Younge
C Kaltschmidt
C M Weyand
J J Goronzy
P2860
P304
P356
10.1172/JCI119477
P407
P577
1997-06-01T00:00:00Z